Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
暂无分享，去创建一个
M. Taniwaki | S. Horiike | J. Kuroda | Y. Shimura | M. Yamamoto-Sugitani | N. Sasaki | M. Ohshiro | H. Uchiyama | C. Shimazaki | Yosuke Matsumoto | Y. Chinen | Tsutomu Kobayashi | H. Nagoshi | M. Kiyota | S. Fuchida | S. Mizutani | Natsumi Sakamoto | Ryuko Nakayama | Mio Yamamoto‐Sugitani | Hisao Nagoshi | Muneo Ohshiro